We are looking for HCM patients without obstruction experiencing shortness of breath,  palpitations, tiring easily, and want to be in a clinical trial. In this trial, HCM non-obstructed patients will have the opportunity to participate in a myosin inhibitor trial,  which assesses the safety and efficacy of mavacamten in this population. Mavacamten is an investigational product that has not been approved by FDA.  

The trial name is ODYSSEY. You might be eligible if you are age 18 or older and experience symptoms related to your HCM. If interested, please click the link to take this quick survey to see if you pre-qualify.  

In the survey, you can identify a clinical trial site and authorize HCMA to share your contact information with them, or you may contact them yourself.  

Access the Survey: https://www.surveymonkey.com/r/BMShcmnon

If you have additional questions, please email linda@4hcm.org or call the office at (973) 983-7429. 

The post ODYSSEY nHCM (aka Hypertrophic Cardiomyopathy without obstruction) appeared first on Hypertrophic Cardiomyopathy Association.